Mebendazole Grindeks

Mebendazole, the active ingredient in Mebendazole Grindeks, is a benzimidazole anthelmintic presented as an oral dosage form for systemic use. It is employed to treat common intestinal worm infections—including ascariasis, hookworm, trichuriasis and enterobiasis—in both children and adults and is widely used in endemic regions.

GNH USA supplies Mebendazole Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides reliable logistics for bulk and parcel shipments across regulated markets.

Mebendazole is an anthelmintic medication used to treat infections caused by intestinal nematodes.

- Ascariasis: eliminates Ascaris lumbricoides worms, reducing egg shedding and gastrointestinal symptoms. - Hookworm infection: eradicates Ancylostoma duodenale and Necator americanus, relieving abdominal discomfort and anemia. - Trichuriasis: clears Trichuris trichiura, improving abdominal pain and blood loss. - Enterobiasis: removes Enterobius vermicularis, stopping perianal itching and reinfection.

Mebendazole may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Abdominal pain: mild cramps. - Nausea: occasional queasiness. - Diarrhoea: transient loose stools. - Headache: mild to moderate.

Serious or Rare Side Effects: - Hepatotoxicity: jaundice or elevated liver enzymes. - Agranulocytosis: marked drop in white blood cells. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: skin blistering and mucosal involvement.

Before prescribing Mebendazole, clinicians should consider several safety considerations. - Pregnancy: use only if potential benefit justifies risk, as safety data are limited. - Liver disease: assess hepatic function because rare hepatotoxicity has been reported. - Blood disorders: monitor complete blood count in patients with pre‑existing hematologic conditions. - Drug interactions: review concomitant medications that may affect tubulin binding or hepatic metabolism. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Mebendazole can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Cimetidine: may increase systemic exposure, raising risk of toxicity. - Itraconazole: strong inhibition of metabolism can lead to elevated levels. - Cyclosporine: combined use may enhance hepatotoxic potential.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce absorption. - Carbamazepine: enzyme induction may lower mebendazole concentrations. - Warfarin: occasional reports of altered anticoagulant effect; monitor INR.